Patents on Tap | The Upcoming Supreme Court Decision in Helsinn v. Teva: Can Secret Sales Invalidate a Patent?

The Supreme Court recently agreed to review Helsinn Healthcare v. Teva Pharmaceuticals, which involves the issue of whether a private sale of an invention (where the details of the invention itself are kept confidential) qualifies as “prior art” under the America Invents Act (AIA) and thereby can be used to invalidate later patents.

Please join us for our next Patents on Tap at Kieran’s Irish Pub in Minneapolis, where Michael Hawkins will give context to the Supreme Court’s decision to review Helsinn and discuss the practical implications this decision may have on businesses and innovators.

Thursday, September 13, 2018
4:00-6:00 PM

Drinks and appetizers will be provided.

Fish & Richardson will apply for 1.0 hour of general CLE.

Register now, as space is limited. If you have questions, please contact Jane Lundberg at [email protected].